-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/behavioral-health-screening-disposition-comments.pdf
April 09, 2025 - The responses to comments in this disposition report are
those of the authors, who are responsible for
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-outcome-measure-harmonization-depression.pdf
November 01, 2020 - The findings and conclusions in this document
are those of the authors, who are responsible for its
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer78_procalcitonin_disposition_20121210.pdf
October 05, 2012 - The responses to comments in this disposition report are
those of the authors, who are responsible for
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-242-radiation-therapy-brain-metastases-disposition-comments.pdf
June 09, 2021 - The responses to comments in this disposition report are
those of the authors, who are responsible for
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ambulatory-safety_research-protocol.pdf
July 24, 2015 - The authors of this report are responsible for its content.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_policymaker.pdf
August 01, 2016 - Policies*
Given the underutilization and the effectiveness of pharmacotherapy
for AUD, individuals responsible
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lifecycle-assessment-disposition-comments.pdf
November 20, 2024 - The responses to comments in this disposition report are
those of the authors, who are responsible for
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-252-infantile-epilepsies-disposition-comments.pdf
October 25, 2022 - The responses to comments in this disposition report are those of the
authors, who are responsible … For the revision, we added that "The
study did not report which baseline medications
were likely responsible
-
effectivehealthcare.ahrq.gov/sites/default/files/tympanostomy-tubes-disposition.pdf
May 05, 2017 - The responses to comments in this disposition report
are those of the authors, who are responsible for
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tympanostomy-tubes-disposition.pdf
May 05, 2017 - The responses to comments in this disposition report
are those of the authors, who are responsible for
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-pancreas_disposition-comments.pdf
September 23, 2014 - The responses to comments in this disposition report are
those of the authors, who are responsible for
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/wheelchair-service_disposition-comments.pdf
January 01, 2012 - The responses to comments in this disposition report are
those of the authors, who are responsible for … The
clinical team is responsible for the prescription and
supporting medical documentation. … The
clinical team is responsible for the prescription and
supporting medical documentation. • The technology … Some VAs have dedicated
Prosthetics/Orthotics staff that are responsible for ordering,
configuring … (b) The medical model, with the physician responsible for
the prescription and the letter of medical
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-267-adhd-disposition-comments.pdf
March 25, 2024 - The responses to comments in this disposition report are
those of the authors, who are responsible
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/plasma-cell-dyscrasias-sflc-assay_executive.pdf
August 01, 2012 - 1
Comparative Effectiveness Review
Number 73
Serum Free Light Chain Analysis for the
Diagnosis, Management, and Prognosis
of Plasma Cell Dyscrasias
Executive Summary
Background
Plasma cell dyscrasias (PCDs) are a group
of neoplastic disorders characterized by
the uninhibited expansion of a monoclonal
popula…
-
effectivehealthcare.ahrq.gov/sites/default/files/data-points-7-tables1.pdf
May 29, 2025 - 1
Table 1. Proportion of Beneficiaries With and Without Cancer Diagnosis Prior to First Biologics Order Among Beneficiaries Satisfying a Period of
Continuous AB FFS Enrollment Prior to First Relevant Claim by Class of Drug, Active Ingredient, and Period of Continuous Enrollment, 2006-2009
Note: An asterisk (*) sign…
-
effectivehealthcare.ahrq.gov/sites/default/files/data-points-7-tables.pdf
May 29, 2025 - 1
Table 1. Proportion of Beneficiaries With and Without Cancer Diagnosis Prior to First Biologics Order Among Beneficiaries Satisfying a Period of
Continuous AB FFS Enrollment Prior to First Relevant Claim by Class of Drug, Active Ingredient, and Period of Continuous Enrollment, 2006-2009
Note: An asterisk (*) sign…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-264-maternal-morbidity-mortality-disposition-comments.pdf
December 21, 2023 - The responses to comments in this disposition report are those of
the authors, who are responsible
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy-update_disposition-comments.pdf
September 10, 2014 - The responses to comments in this disposition report are
those of the authors, who are responsible for
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/bundled-payments-quality-effects_disposition-comments.pdf
August 24, 2012 - The responses to comments in this disposition report
are those of the authors, who are responsible for
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-risk-drugs-protocol.pdf
July 27, 2023 - The authors of this report are
responsible for its content.